Thursday, March 02, 2006

this may be very good news...

this may be very good news...

ive been watching this drug for the last ten years...
its the only promising drug or treatment to come about in fifteen years...

eight years ago, the medical community decided to not concentrate so much on a cure, but in finding a way to make aids a managable chronic disease... just like they did with diabetes...

do you know why the shift in focus?
can you guess?
come oooooooon... guess...

MOOOOOOOLAH! if you can keep em alive, you can make more MOOOOOOOOOOLAH...

bastards...

the following came from queerfmnews.com

Drug companies, Merck & Co. and Gilead Sciences have reported successful small-scale tests of an integrase inhibitor, in the fight against HIV.

Most successful AIDS drugs inhibit the protease or reverse transcriptase enzymes HIV uses to make copies of itself, no drug on the market has targeted the third HIV enzyme, integrase.

Now researchers may finally have found a potent new class of AIDS drugs, known as integrase inhibitors.

According to Merck, the new anti-viral drug reduced HIV viral loads to undetectable levels 72 percent of the time in the most responsive dosage group of 167 patients in a four-month trial. The company is now enrolling volunteers for a large-scale study. If successful, its integrase inhibitor would be on track for U.S. Food and Drug Administration approval in 2007.

Gilead Sciences made a similar announcement on Wednesday. Its integrase inhibitor dramatically reduced viral loads by as much as 99 percent in a 10-day trial involving 40 patients.

"If these drugs were to be approved, it would be a great new development,"
said Dr. Frenk Guni, the director for international affairs for the National Association of People with AIDS.

"It would provide greater opportunities for people who have developed a resistance to other AIDS drugs," he said.

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home